Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Did you mean 902 4s 9?
Displaying drugs 1176 - 1200 of 1784 in total

Onvansertib

Onvansertib is under investigation in clinical trial NCT03303339 (Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML).).
Investigational

Lunasine

Lunasine is under investigation in clinical trial NCT02709330 (ALS Reversals - Lunasin Regimen).
Investigational
Matched Iupac: … (2R)-4,8-dimethoxy-9-methyl-2-(propan-2-yl)-2H,3H-furo[2,3-b]quinolin-9-ium …

Larsucosterol

Investigational

Rebisufligene etisparvovec

Investigational

(5S,7R,8S,9S,10R)-3-Amino-8,9,10-trihydroxy-7-(hydroxymethyl)-6-oxa-1,3-diazaspiro[4.5]decane-2,4-dione

Experimental

(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol

Experimental

Heptaethylene glycol

Experimental

Ifinatamab deruxtecan

Investigational

Selisistat

Selective inhibitor of SIRT1 that does not inhibit histone deacetylase (HDAC) or other sirtuin deacetylase family members (IC50 values are 98, 19600, 48700, > 100000 and > 100000 nM for SIRT1, SIRT2, SIRT3, HDAC and NADase respectively). Enhances p53 acetylation in response to DNA damaging agents.
Experimental

3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE

Experimental

Homochlorcyclizine

Experimental

3,6,9,12,15,18-HEXAOXAICOSANE

Experimental

Canoctakin

Investigational

XR5944

XR5944 is a DNA bis-intercalating anticancer drug. It has both intercalating and antineoplastic activities.
Investigational
Matched Iupac: … 9-methyl-N-(2-{[2-({2-[(9-methylphenazin-1-yl)formamido]ethyl}amino)ethyl]amino}ethyl)phenazine-1-carboxamide …

N-[(5S,7R,8S,9S,10R)-8,9,10-Trihydroxy-7-(hydroxymethyl)-2,4-dioxo-6-oxa-1,3-diazaspiro[4.5]dec-3-yl]acetamide

Experimental

Dectaflur

Experimental
Matched Iupac: … (9Z)-octadec-9-en-1-amine hydrofluoride …

Zilovertamab

Investigational

Cobamamide

Cobamamide is one of the active forms of vitamin B12 that is also known as adenosylcobalamin or dibencozide. This drug is available as a nutritional supplement to prevent vitamin B12 deficiency. Vitamin B12 is a collective term for these variously substituted corrinoids. The principal biochemical participants are two coenzyme forms...
Nutraceutical
Matched Iupac: … (10S,12R,13S,17R,23R,24R,25R,30S,35S,36S,40S,41S,42R,46R)-1-{[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl) ... 2,9}.1^{10,13}.0^{1,26}.0^{3,8}.0^{23,27}.0^{25,42}.0^{32,44}.0^{39,43}.0^{37,45}]heptatetraconta-2(47 …

3,6,9,12,15-Pentaoxaheptadecane

Experimental

5-(2-hydroxyethyl)nonane-1,9-diol

Experimental

Carbazole Butanoic Acid

Experimental
Matched Iupac: … 4-(9H-carbazol-9-yl)butanoic acid …

Oleic monoethanolamide

Investigational
Matched Iupac: … (9Z)-N-(2-hydroxyethyl)octadec-9-enamide …

Irosustat

Irosustat has been investigated for the treatment of Metastatic Breast Cancer and Locally Advanced Breast Cancer.
Investigational

anti-OX40 antibody BMS 986178

A macrocyclic peptide (BMS-986189) with activity in binding and functional assays comparable to a PD-L1 antibody.
Investigational

Paxalisib

GDC-0084 is under investigation in clinical trial NCT03696355 (Study of GDC-0084 in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline Gliomas).
Investigational
Displaying drugs 1176 - 1200 of 1784 in total